Medcxy · Blog
Compliance guides, regulatory data explainers and AI workflows — written for medical aesthetics professionals.
Compliance rules, registry data and AI workflows, written for the people who have to make the call every day. Everything here comes from the same rule base and the same registry sources the Medcxy product runs on, with the source visible for every conclusion.
The Chinese rules behind medical aesthetics ads, why botulinum toxin can't be advertised, why paid KOL posts are the top risk, and a pre-publication checklist.
A step-by-step guide to verifying NMPA approval in China: reading 国械注 and 国药准字 numbers, searching the official database, and spotting red flags.
What compliance AI actually does for aesthetics teams — sentence-level rule checking, risk grading, cited rules and rewrite suggestions — plus six questions to ask any vendor claiming to do it.
A comparison of the tools that actually appear in this category — Pabau, Nextmotion, Clinicminds, Zenoti, Aesthetic Record, AestheticsPro for clinic operations, and IQVIA, Clarivate and Medcxy for compliance and regulatory data — plus how to tell which category you need.
Using mainstream hyaluronic acid fillers as an example, we walk through the differences between China's NMPA, the US FDA, EU CE/MDR, Japan's PMDA and Korea's MFDS — and how to quickly verify a product's global approval status.
Superlatives, efficacy guarantees, price baiting — a practical guide to the 10 most common violations in medical aesthetics advertising, with rewrite strategies and a platform-by-platform review comparison.
Written by the Medcxy data and compliance teams from public regulations and registry sources. We revisit articles when the underlying rules change.